[14]
The result of the proceeding usually carries significant weight because, as a general rule, costs should follow the event: Merck & Co. v. Novopharm Ltd. (1998), 82 C.P.R. (3d) 457 (F.C.T.D.) at 464. Where success has been fairly evenly divided, however, there should normally be no order as to costs: Lubrizol Corp. v. Imperial Oil Ltd. (1996), 67 C.P.R. (3d) 1 (F.C.A.) at 25.